Why the study?
Atherosclerosis is a major cause of worldwide mortality, and the study aimed to investigate the role of diabetes in atherosclerotic plaque growth mechanisms using a multi-level numerical model.
Does a computational multi-level model incorporating diabetes effects accurately predict atherosclerotic plaque growth in coronary arteries?
Does a computational multi-level model incorporating diabetes effects accurately predict atherosclerotic plaque growth in coronary arteries?
A computational multi-level model incorporating diabetes effects demonstrated a high coefficient of determination (0.634) in predicting atherosclerotic plaque growth compared to real follow-up geometries.
Model shows promise for plaque prediction in diabetes; leaves open larger prospective validation before clinical use.
Atherosclerosis is the one of the major causes of mortality worldwide, urging the need for its treatment. This study is aiming to investigate the role of diabetes in the atherosclerotic plaque growth mechanisms through the utilization of a multi-level numerical model. To accomplish this, we developed a proof-of-concept mathematical model of the diabetes effect to plaque growth, that has been coupled to a stateof-the-art multi-level numerical model of plaque growth. Diabetes main effect is the increase of the average blood glucose concentration, which causes the decrease of the endothelial nitric oxide production rate by affecting several biologic pathways. Nitric oxide is a signaling molecule that regulates the endothelial flow rates, and any abnormal alteration leads to endothelial dysfunction, the major culprit of atherosclerosis. The derived model considers the modeling of blood flow in lumen and of species transport and reactions in the arterial wall. The considered factors include: (i) LDL, (ii) HDL, (iii) oxidized LDL, (iv) monocytes, (v) macrophages, (vi) cytokines, (vii) smooth muscle cells (contractile & synthetic), and (viii) collagen. The model is validated using 10 patients' reconstructed arterial data in two time-points. More specifically, baseline geometries are used as an input to our model, while follow-up geometries are used as benchmark for our model's output. The results presented a high coefficient of determination between the simulated with diabetes effect and the real follow-up geometries of 0.634.
No takes yet. Share an insight, caveat, or question.
Pleouras et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: